Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Infiltrates”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)UnknownNCT03903887
What this trial is testing

Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 20
Not applicableActive Not RecruitingNCT03168815
What this trial is testing

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

Who this might be right for
ImmunocompromisedHematologic MalignancyPost Hematopoietic Stem Cell Transplant+2 more
Mount Sinai Hospital, Canada 98
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Study completedNCT03853187
What this trial is testing

Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Radboud University Medical Center 20
Large-scale testing (Phase 3)Study completedNCT02353702
What this trial is testing

Efficacy of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery

Who this might be right for
Hepatectomy
University Hospital, Rouen 31
Testing effectiveness (Phase 2)Looking for participantsNCT05361174
What this trial is testing

Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Iovance Biotherapeutics, Inc. 53
Not applicableLooking for participantsNCT06519669
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer

Who this might be right for
AdultLung Cancer
Grit Biotechnology 40
Early research (Phase 1)Looking for participantsNCT05681780
What this trial is testing

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Post-approval studies (Phase 4)Ended earlyNCT03642457
What this trial is testing

Efficacy Between Serratus Plane Block And Local Infiltration In Vats

Who this might be right for
Lung Cancer
Icahn School of Medicine at Mount Sinai 65
Early research (Phase 1)Looking for participantsNCT07192900
What this trial is testing

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
David Bartlett, MD 10
Testing effectiveness (Phase 2)WithdrawnNCT03419559
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Early research (Phase 1)Looking for participantsNCT07443020
What this trial is testing

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 10
Early research (Phase 1)Ended earlyNCT05035407
What this trial is testing

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Who this might be right for
Kita-kyushu Lung Cancer Antigen 1, Human
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT02848872
What this trial is testing

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
Duke University 25
Not applicableStudy completedNCT04658953
What this trial is testing

Comparison of the Effectiveness of Ultrasound-guided Versus Radioguided Medial Lumbar Bundle Branch Block

Who this might be right for
Chronic Low-back PainLumbar Facet Joint Syndrome
Centre Hospitalier Universitaire Saint Pierre 50
Not applicableLooking for participantsNCT06235242
What this trial is testing

GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer

Who this might be right for
AdultNon-small Cell Lung Cancer
Grit Biotechnology 20
Not applicableActive Not RecruitingNCT05157659
What this trial is testing

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer
Amsterdam UMC, location VUmc 10
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Load More Results